Chris Torrance

 Chris Torrance
Chris Torrance
Chief Executive Officer
PhoreMost Ltd

Presentations at Drug Discovery 2015

Wed2  Sep09:15am(45 mins)
Keynote: Phenotypic Screening for Novel Druggable Targets Using "Protein-Interference"

Session: Innovation in Assay Development & Screening
Room: To be announced

Profile of Chris Torrance

Dr Chris Torrance is CEO of PhoreMost Ltd; a company he founded with Ashok Venkitaraman in 2014 to systematically de-orphan key disease-driving targets currently considered undruggable by the pharma-industry. Dr Torrance previously founded Horizon Discovery; a biotech company developing and exploiting genetically-defined human disease models for personalized medicine research and drug discovery. Horizon listed on the London Stock Exchange in 2014 and received the Queens Award for International Trade in 2012. Prior to Horizon, Dr Torrance was Head of Oncology at the UK Biotechnology company Vernalis PLC (LSE: VER), where he was responsible for progressing several novel kinase oncology programs.
Please login to send a Private Message

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018